Sirius MRI Markers Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles
510(k) K202267
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK202267 | Date31 Dec 2020 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KXK
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.5730
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
This device is a brachytherapy radionuclide source designed for the delivery of radioactive Cs-131 implants. It consists of preloaded strands equipped with MRI-compatible markers for precise localization during and after implantation, ensuring accurate radiation therapy targeting in oncology procedures.
The Sirius MRI Markers Cs-131 Preloaded Strands are supplied sterile and intended for single-use in radiology settings. Each strand is housed in an 18 gauge needle, facilitating implantation into malignant prostatic tissue. The markers enhance MRI visibility, aiding in post-procedure verification, and comply with FDA 510(k) clearance under regulation number 892.5730, classified as a Class II device.